Stem cell injections for mouth fibrosis in scleroderma
Treatments studied
Part of Genetic & congenital, Mouth & dental, Skin clinical trials.
This trial tests whether injections of donor stem cells can reduce mouth tightness and improve daily function in people with systemic sclerosis (scleroderma). It focuses on those with significant mouth involvement and limited mouth opening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with systemic scleroderma using standard criteria.
- Your mouth symptoms score is at least 20 out of 48.
- Your maximum mouth opening is less than 40 mm (about 1.6 inches).
- You are able to understand and follow the study procedures.
- You are covered by a health insurance plan (for French participants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cells from umbilical cords can help people with scleroderma-related lung disease that is getting worse. You may qualify if your lung function has declined despite current treatments.
This trial tests if injecting fat-derived stem cells into the salivary glands can help relieve dry mouth in people with Sjögren's disease. It aims to improve saliva flow and reduce discomfort.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
This trial tests whether infusions of donor stem cells from fat tissue can help people with severe systemic sclerosis (a serious autoimmune disease that hardens the skin and can affect internal organs). It is for patients who haven't improved with other treatments or cannot undergo a standard stem cell transplant.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This trial tests whether special cells from umbilical cord (UC-MSC) can help treat systemic sclerosis—a disease that causes skin and organ hardening. If you have early systemic sclerosis that hasn't improved enough with standard treatments, this study may offer a new option.
Hear when a new Systemic Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.